New insulins for diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-2900|32|3|93-98

ISSN： 2047-2897

Source： PRACTICAL DIABETES (INCORPORATING CARDIABETES), Vol.32, Iss.3, 2015-04, pp. : 93-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative risks of diabetes‐related complications of basal insulins: a longitudinal population‐based cohort of type 1 diabetes 1999–2013 in Taiwan

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 379-391

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar insulins: a European perspective

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 5, 2015-05 ,pp. : 445-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

The place for rapid‐acting insulins in therapy

By  

PRESCRIBER, Vol. 26, Iss. 8, 2015-04 ,pp. : 27-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: New treatment of diabetes mellitus

By Lechleitner Monika  

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 281-281

Springer Publishing Company

Access to resources Recommend Favorite

New treatments for type 2 diabetes

By Cascales Laura  

Medical Writing, Vol. 21, Iss. 4, 2012-12 ,pp. : 279-283

Maney Publishing

Access to resources Recommend Favorite